Skip to main content

Andy Kim on Strengthening U.S. Drug Supply Chains Against Foreign Activity

Forbes Breaking NewsOctober 7, 20256 min532 views
10 connections·15 entities in this video

The Need for Drug Supply Chain Resilience

  • 🇺🇸 Senator Andy Kim emphasizes the critical need to enhance the manufacturing and supply chain for pharmaceuticals in the United States.
  • 💡 This resilience is crucial not only for national security but also for maintaining the economic competitiveness of the U.S.

Market-Based Resilience Models

  • 🎯 A market-based resilience benchmark is discussed, drawing parallels to how sophisticated multinational companies manage their own supply chains.
  • 🔑 Companies ensure resilience by diversifying suppliers (never buying from one source), inspecting facilities, and establishing long-term contracts to secure key ingredients for their products.
  • ⚠️ This approach is presented as a normal business practice that prevents shortages, except for unusual demand spikes.

Government's Role in Supply Chain Security

  • ⚖️ The challenge lies in applying this model at a societal level, where the government can act as a buyer with a rational reason to create a resilient supply.
  • 💰 Government can create benchmarks to help buyers understand how to pay for quality and establish incentives or mandates for contracts that reward high-scoring suppliers.
  • 🏥 Hospital-administered drugs, a common source of shortages, are identified as an area where the federal government can leverage its purchasing power.

Quality Assessment and FDA Support

  • 📊 The FDA's existing risk-adjusted site selection scores could be adapted into a five-star rating system for drugs, indicating facility risk levels.
  • 🔍 While the FDA possesses this data, they may be resistant to sharing it for public use, but it serves as a potential starting point for quality assessment.
  • 🛠️ Investment in FDA investigators is crucial, including enhanced training and support for challenging foreign inspections, which are vital for identifying potential harm.
  • 📈 Unannounced inspections are significantly more effective (four times greater chance) at identifying problems compared to announced ones.
Knowledge graph15 entities · 10 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover · drag to explore
15 entities
Chapters4 moments

Key Moments

Transcript25 segments

Full Transcript

Topics13 themes

What’s Discussed

Drug Supply ChainPharmaceutical ManufacturingNational SecurityEconomic CompetitivenessResilienceMarket-Based ResilienceGovernment RoleFDAQuality AssessmentForeign RegulatorsSupply Chain SecurityHospital-Administered DrugsUnannounced Inspections
Smart Objects15 · 10 links
Locations· 2
Companies· 2
Concepts· 8
Product· 1
Person· 1
Event· 1